{"id":"W2143715586","doi":"10.1016/j.ctrv.2015.07.003","title":"Obinutuzumab in hematologic malignancies: Lessons learned to date","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pfizer; F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Obinutuzumab; Hematologic Neoplasms; Oncology; Intensive care medicine; Internal medicine; Cancer; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001069786,0.0006734693,0.001906138,0.001862657,0.0002507506,0.001433401,0.0008170829,0.001046179,0.003802008],"category_scores_gemma":[0.001921846,0.0002639027,0.0008381375,0.002017165,0.0004392128,0.001522123,0.0008198559,0.001965857,0.0008195087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007371085,"about_ca_system_score_gemma":0.001777009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001562653,"about_ca_topic_score_gemma":0.004737709,"domain_scores_codex":[0.9997247,0.00006294309,0.00005387711,0.00004875401,0.00007845326,0.00003137246],"domain_scores_gemma":[0.9991484,0.0005101167,0.0001239286,0.00001602612,0.0001454728,0.00005618638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001973478,0.00006011116,0.0002588548,0.03362194,0.0003016585,0.00008966896,0.0000550739,0.0002644687,0.0005788666,0.002186277,0.04149415,0.9208915],"study_design_scores_gemma":[0.0001069218,0.0001413343,0.0009230283,0.02040842,0.0009174506,0.0005741298,0.00009991333,0.0001136308,0.0002751567,0.001969941,0.9744467,0.00002340224],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004328468,0.9994191,0.00002536243,0.0002265849,0.00009798071,0.000001647725,0.00001121103,0.000002493823,0.0001723314],"genre_scores_gemma":[0.0004246539,0.9988701,0.00008246153,0.0003253182,0.0001295038,0.00000293001,0.00001631556,9.447418e-7,0.0001477217],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003802008,"threshold_uncertainty_score":0.01271898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4738322693286079,"score_gpt":0.5435361784067422,"score_spread":0.06970390907813429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}